Behavioral Economics to improve Antihypertensive Therapy Adherence (BETA)
Behavioral Economics to improve Antihypertensive Therapy Adherence (BETA)
批准号:
10399491
负责人:
Joseph Ebinger
金额:
$22.37万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-05-01 至 2024-04-30
关键词:
AdherenceAdverse eventAmericanAntihypertensive AgentsAttentionBehaviorBehavioralBlood PressureBody Weight decreasedCardiovascular systemCaringCessation of lifeClinicClinical PharmacistsClinical TrialsCognitiveCommunity Health AidesComplementControl GroupsCuesDataData CollectionDrug PrescriptionsEatingEducationEffectiveness of InterventionsEventExerciseFatigueFeedbackFocus GroupsFutureHealth ExpendituresHeart failureHypertensionIncentivesIncreased frequency of micturitionInterventionLibidoLife Style ModificationLinkMeasuresMedicalMotivationMyocardial InfarctionNursesOutcomeOutcome StudyParticipantPatientsPharmaceutical PreparationsPharmacistsPhasePhysiciansPopulationPreparationProviderPublic HealthRandomized Controlled TrialsReactionResearchResourcesRewardsRiskRisk FactorsStrokeSurveysTestingText MessagingTimeToothbrushingUnited StatesWorkacceptability and feasibilitybasebehavioral economicsblood pressure controlblood pressure elevationblood pressure reductioncardiovascular disorder riskcardiovascular risk factorclinical practicecostdietary salteffective interventionfinancial incentivegroup interventionhypertension controlhypertensiveimprovedinsightintrinsic motivationmedication compliancemedication nonadherencenovelnovel strategiesphase 2 testingpillprimary outcomerelative effectivenessresponsescale upsecondary outcomeside effecttherapy adherencetherapy designtherapy development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Hypertension is one of the most prevalent cardiovascular disease risk factors, with over 45% of the United States
population having elevated blood pressure. Decades of research have demonstrated that controlling blood
pressure can reduce the risk of serious adverse cardiovascular events including stroke, myocardial infarction,
and heart failure. A key component of successfully obtaining control of hypertension is the use of medications to
lower blood pressure. Unfortunately, more than 50% of Americans demonstrate medication non-adherence, a
statistic that directly contributes to suboptimal blood pressure control and, therefore, excess preventable
cardiovascular events. Strong data indicates that linking the taking of medications to daily routines (‘anchoring’)
increases adherence, however, existing interventions built on this information have failed to create successful,
long term improvements in medication adherence. This study aims to leverage behavioral economic insights to
improve medication adherence to antihypertensive medications. Specifically, we propose to complement linking
medication taking to a daily routine with two added components to make it easier for participants to stick to their
anchoring plan: increasing information salience through frequent text messages and providing intermittent
rewards for pill-taking according to the anchoring plan. This study will be implemented in a pilot randomized
controlled trial (RCT) in a high-volume clinical practice to establish feasibility, acceptability, and preliminary
efficacy. The specific aims include 1) a formative phase to develop the intervention and evaluate its feasibility
and acceptability via focus groups with key stakeholders; 2) a RCT of 60 hypertensive patients in which a control
group (n=20) is provided education on anchoring medication taking to a daily routine, and two intervention
groups, one (n=20) who receives anchoring education and daily text message reminders and another (n=20)
which receives anchoring education, text messages, and financial incentives for adherence in accordance with
their anchoring plan; and 3) data collection in preparation for a future R01 application, including focus group
discussions with key stakeholders (patients, providers [Physicians, Nurses, Advanced Care Practitioners,
Pharmacists] and clinic staff) and exit focus groups with study participants regarding ways to improve the
intervention. The main hypothesis is: the intervention is effective by anchoring pill-taking to an existing routine,
tested by comparing the pooled (Message group + Incentive group) vs. the Control group. The secondary
hypothesis is: adding incentives to the text messages is more effective for routinizing pill-taking (testing outcomes
in the Incentive group vs. Message group). Outcomes from this study have the potential to greatly enhance our
understanding of the barriers and facilitators of medication adherence among hypertensive patients and
potentially provide evidence for a low-cost and scalable intervention to improve medication adherence in clinical
practice.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1136/bmjopen-2022-066101
发表时间:
2023-01-25
期刊:
BMJ open
影响因子:
2.9
作者:
[]
通讯作者:
Implementation Science to Improve Cardiovascular Health: Leveraging EHR Systems to Advance Care of Resistant Hypertension
-
批准号:10439510
-
项目类别:
-
资助金额:$17.61万
-
财政年份:2020
-
负责人:Joseph Ebinger
-
依托单位:
Implementation Science to Improve Cardiovascular Health: Leveraging EHR Systems to Advance Care of Resistant Hypertension
-
批准号:10216356
-
项目类别:
-
资助金额:$17.61万
-
财政年份:2020
-
负责人:Joseph Ebinger
-
依托单位:
Implementation Science to Improve Cardiovascular Health: Leveraging EHR Systems to Advance Care of Resistant Hypertension
-
批准号:10041734
-
项目类别:
-
资助金额:$17.61万
-
财政年份:2020
-
负责人:Joseph Ebinger
-
依托单位:
Implementation Science to Improve Cardiovascular Health: Leveraging EHR Systems to Advance Care of Resistant Hypertension
-
批准号:10630490
-
项目类别:
-
资助金额:$4.84万
-
财政年份:2020
-
负责人:Joseph Ebinger
-
依托单位:
Implementation Science to Improve Cardiovascular Health: Leveraging EHR Systems to Advance Care of Resistant Hypertension
-
批准号:10653690
-
项目类别:
-
资助金额:$17.61万
-
财政年份:2020
-
负责人:Joseph Ebinger
-
依托单位:
海外基金